Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk

内源性大麻素-阿片类药物串扰的回路和突触机制

基本信息

项目摘要

Project Summary For the past decade, the use of opioids has risen dramatically in the United States and the disproportional increase in opioid dependence and overdose death has led to the current opioid crisis. Although different measures have been taken to reduce opioid overutilization for pain management, opioid use in clinics continues leading to dependence and overdose. In there is a compelling need for non-opioid use of pharmacological addition, for the significant number of people with opioid use disorder, pharmacological therapies to complement current treatments for opioid disorder. A major challenge is to develop new treatment strategies that can attenuate the rewarding aspects opioids while preserving their powerful analgesic properties. endocannabinoid (eCB) system serves as a potential target for the development of new treatments as a complement to opioid based treatments. Several lines of evidence suggest The functional interaction between the opioid and the eCB system at the level of neurochemical, neuroanatomical and molecular pathways. Our preliminary results find that indirectly enhancing levels of the endocannabinoid 2- AG levels through pharmacological inhibition of its catabolic enzyme, monoacylglycerol lipase (MAGL), attenuates the rewarding effects of morphine, while maintaining its analgesic effects. In this proposal we will dissect at a circuit, synaptic and molecular level how elevated 2-AG attenuates opioid reward. Recent studies have underscored the role of local GABAergic neuronal inputs from the rostromedial tegmental nucleus (RMTg) in regulating the ventral tegmental area (VTA), a key dopaminergic brain region involved in opioid reward. Opioids are thought to act by disinhibiting RMTg inhibition onto VTA dopamine neurons by activating presynaptic mu opioid receptors (MOR), subsequently increasing dopamine cell firing and nucleus accumbens (NAc) activity that drives reward. However, little is known about how cannabinoid receptors (CB1R) and MORs signal and crosstalk at these key synapses. Aim 1 will examine 2-AG mechanisms in the VTA on opioid reward behavior and its effect on NAc dynamics. Aim 2 will examine the role of CB1R and MOR in the RMTg→VTA projection on opioid reward behavior and NAc dynamics. Aim 3 will examine synaptic and molecular mechanisms of CB1R and MOR crosstalk to determine how enhancing 2-AG levels leads to blunted opioid reward.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Francis Sang Yong Lee其他文献

Francis Sang Yong Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Francis Sang Yong Lee', 18)}}的其他基金

Molecular and synaptic mechanisms of neurotrophin-glutamate crosstalk
神经营养蛋白-谷氨酸串扰的分子和突触机制
  • 批准号:
    10586395
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid Crosstalk
内源性大麻素-阿片类药物串扰的回路和突触机制
  • 批准号:
    10709494
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
Molecular and Synaptic Mechanisms of Neurotrophin-glutamate Crosstalk
神经营养蛋白-谷氨酸串扰的分子和突触机制
  • 批准号:
    10710401
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
Impact of BDNF on the Development of Social Behavior Circuits
BDNF 对社会行为回路发展的影响
  • 批准号:
    10556426
  • 财政年份:
    2020
  • 资助金额:
    $ 78.67万
  • 项目类别:
Molecular Mechanisms of SSRI Action in Childhood and Adolescence
SSRI 在儿童和青少年时期作用的分子机制
  • 批准号:
    7938928
  • 财政年份:
    2009
  • 资助金额:
    $ 78.67万
  • 项目类别:
Molecular Mechanisms of SSRI Action in Childhood and Adolescence
SSRI 在儿童和青少年时期作用的分子机制
  • 批准号:
    7832616
  • 财政年份:
    2009
  • 资助金额:
    $ 78.67万
  • 项目类别:
Functional analysis of variant BDNF (Val66Met)
BDNF 变体 (Val66Met) 的功能分析
  • 批准号:
    7071230
  • 财政年份:
    2005
  • 资助金额:
    $ 78.67万
  • 项目类别:
Functional analysis of variant BDNF (Val66Met)
BDNF 变体 (Val66Met) 的功能分析
  • 批准号:
    8044863
  • 财政年份:
    2005
  • 资助金额:
    $ 78.67万
  • 项目类别:
Functional analysis of variant BDNF (Val66Met)
BDNF 变体 (Val66Met) 的功能分析
  • 批准号:
    7586209
  • 财政年份:
    2005
  • 资助金额:
    $ 78.67万
  • 项目类别:
Functional analysis of variant BDNF (Val66Met)
BDNF 变体 (Val66Met) 的功能分析
  • 批准号:
    7391103
  • 财政年份:
    2005
  • 资助金额:
    $ 78.67万
  • 项目类别:

相似海外基金

Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
  • 批准号:
    10641500
  • 财政年份:
    2023
  • 资助金额:
    $ 78.67万
  • 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
  • 批准号:
    10485593
  • 财政年份:
    2023
  • 资助金额:
    $ 78.67万
  • 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
  • 批准号:
    10728526
  • 财政年份:
    2023
  • 资助金额:
    $ 78.67万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 78.67万
  • 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
  • 批准号:
    10621646
  • 财政年份:
    2023
  • 资助金额:
    $ 78.67万
  • 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
  • 批准号:
    22K19602
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10425794
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
  • 批准号:
    10512672
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
  • 批准号:
    10821681
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10721752
  • 财政年份:
    2022
  • 资助金额:
    $ 78.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了